Status of common sexually transmitted infection in population referred for colposcopy and correlation with human papillomavirus infection

Table 1 Comparison of infection rate of detected STI pathogens under different HR-HPV infection status

STIs	Total / N	HR-HPV Positive N = 615	HR-HPV negative N = 104	Х²	P
C. trachomatis	86	75 (12.2%)	11 (10.6%)	0.221	0.745
U. urealyticum	104	85 (13.8%)	19 (18.3%)	1.423	0.230
M. hominis	43	37 (6.0%)	6 (5.8%)	0.010	1.000^*
M. genitalium	9	9 (1.5%)	0 (0.0%)	1.541	0.371
U. parvum serovar 1	60	49 (8.0%)	11 (10.6%)	0.792	0.343
U. parvum serovar 3	129	119 (19.3%)	10 (9.6%)	5.725	0.018
U. parvum serovar 6	145	132 (21.5%)	13 (12.5%)	4.439	0.035
U. parvum serovar 14	5	5 (0.8%)	1 (1.0%)	0.024	1.000^*
N. gonorrhoeae	8	7 (1.1%)	1 (1.0%)	0.025	1.000^*
HSV-2	36	35 (5.7%)	1 (1.0%)	4.184	0.048
Single infection	318	277 (45.0%)	39 (37.5%)	6.242	0.044
Multiple infection	142	126 (20.5%)	16 (15.4%)	6.242	0.044

* Fisher’s exact test. Multiple infections double counting
HR-HPV, high-risk human papillomavirus; STIs, sexually transmitted infections; C. trachomatis, Chlamydia Trachomatis; U. urealyticum, Ureaplasma urealyticum; M. hominis, Mycoplasma hominis; M. genitalium, Mycoplasma genitalium; U. parvum, Ureaplasma parvum; N. gonorrhoeae, Neisseria Gonorrhoeae; HSV-2, herpes simplex virus 2

ISSN: 1472-6874